Submission Details
| 510(k) Number | K972609 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 11, 1997 |
| Decision Date | August 06, 1997 |
| Days to Decision | 26 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K972609 is an FDA 510(k) clearance for the VARIANT EXPRESS GLYCOHEMOGLOBIN PROGRAM, a Fluorescent Immunoassay Gentamicin (Class II — Special Controls, product code LCQ), submitted by Bio-Rad (Hercules, US). The FDA issued a Cleared decision on August 6, 1997, 26 days after receiving the submission on July 11, 1997. This device falls under the Hematology review panel. Regulated under 21 CFR 862.3450.
| 510(k) Number | K972609 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 11, 1997 |
| Decision Date | August 06, 1997 |
| Days to Decision | 26 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | LCQ — Fluorescent Immunoassay Gentamicin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3450 |